The efficacy of citalopram in depression and quality of life in the patients with cardiac disease
Not Applicable
- Conditions
- Condition 1: Acute Coronary Syndrome. Condition 2: Acute Coronary Syndrome.Unstable AnginaAcute Myocardial Infarction
- Registration Number
- IRCT2016091722991N6
- Lead Sponsor
- Vice Chancellor for research of Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
admission in cardiac care units because of acute coronary syndrome; age more than 18 years; women in reproductive ages who are not pregnant and do not want to have pregnancy in duration of the study; assignment the informed consent form of the study
Exclusion criteria: past history of intolerance to selective serotonin reuptake inhibitors; severe and life threatening medical conditions which inhibit the participation of the patient in duration of the study; severe congestive heart failure with diagnosis of the cardiologist; dependence to alcohol or other addictive drugs; psychosis or dementia or mental retardation in patient; pregnancy and breast feeding; history of elevated mood
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient´s depressive condition. Timepoint: 3th and 8th weeks after treatment. Method of measurement: Hospital Anxiety and Depression Scale.;Patient´s quality of life. Timepoint: 3th and 8th weeks after treatment. Method of measurement: SF-36 Quality of Life Questionnaire.
- Secondary Outcome Measures
Name Time Method Adverse drug reaction. Timepoint: 3rd and 8th weeks after treatment. Method of measurement: psychiatric visit.